TUDCA (Tauroursodeoxycholic Acid) Supplementation

DRUG2 trials

Sponsors

Tsinghua University, Tongji Hospital

Conditions

Hepatocellular CarcinomaInfluenza Vaccine Response

Phase 2

Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study

Not yet recruitingNCT07064668

Tongji HospitalHepatocellular Carcinoma

Start: 2025-07-30End: 2027-12-30Target: 300Updated: 2025-07-15

Unknown Phase

Effect of Oral Supplements for Influenza Vaccine Response

Not yet recruitingNCT06827873

Tsinghua UniversityInfluenza Vaccine Response

Start: 2025-02-28End: 2025-10-31Target: 45Updated: 2025-02-14